SCM

Superstring Capital Management Portfolio holdings

AUM $80.3M
1-Year Return 68.23%
This Quarter Return
+57.27%
1 Year Return
+68.23%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$32.5M
Cap. Flow
+$29.7M
Cap. Flow %
26.58%
Top 10 Hldgs %
77.69%
Holding
47
New
8
Increased
7
Reduced
9
Closed
20

Top Buys

1
GPCR icon
Structure Therapeutics
GPCR
$9.97M
2
ZLAB icon
Zai Lab
ZLAB
$9.94M
3
ORIC icon
Oric Pharmaceuticals
ORIC
$9.73M
4
TIL icon
Instil Bio
TIL
$7.24M
5
CAPR icon
Capricor Therapeutics
CAPR
$5.13M

Top Sells

1
LEGN icon
Legend Biotech
LEGN
$4.59M
2
KROS icon
Keros Therapeutics
KROS
$3.39M
3
ACLX icon
Arcellx
ACLX
$3.26M
4
ARWR icon
Arrowhead Research
ARWR
$2.89M
5
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$1.78M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LSB
26
LakeShore Biopharma
LSB
$34.9M
$212K 0.19%
30,792
– –
CLYM
27
Climb Bio, Inc. Common Stock
CLYM
$162M
$172K 0.15%
+33,824
New +$172K
MRSN icon
28
Mersana Therapeutics
MRSN
$34.8M
– –
-4,403
Closed -$221K
NAMS icon
29
NewAmsterdam Pharma
NAMS
$2.81B
– –
-64,213
Closed -$1.23M
PEPG icon
30
PepGen
PEPG
$41.7M
– –
-29,249
Closed -$467K
PYXS icon
31
Pyxis Oncology
PYXS
$94.9M
– –
-484,443
Closed -$1.6M
ATYR
32
aTyr Pharma
ATYR
$539M
– –
-313,028
Closed -$488K
ONC
33
BeOne Medicines Ltd. American Depositary Shares
ONC
$35.3B
– –
-12,508
Closed -$1.78M
SPRB
34
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
– –
-77,992
Closed -$40.4K
SYRS
35
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-37,789
Closed -$195K
MRNS
36
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-261,861
Closed -$306K
ACLX icon
37
Arcellx
ACLX
$3.94B
– –
-59,133
Closed -$3.26M
ALLK
38
DELISTED
Allakos
ALLK
– –
-940,578
Closed -$941K
APGE icon
39
Apogee Therapeutics
APGE
$2.22B
– –
-36,928
Closed -$1.45M
ARWR icon
40
Arrowhead Research
ARWR
$3.84B
– –
-111,133
Closed -$2.89M
CATX icon
41
Perspective Therapeutics
CATX
$253M
– –
-87,638
Closed -$874K
CMPS
42
Compass Pathways
CMPS
$480M
– –
-32,497
Closed -$196K
CTMX icon
43
CytomX Therapeutics
CTMX
$336M
– –
-1,151,518
Closed -$1.4M
EYPT icon
44
EyePoint Pharmaceuticals
EYPT
$799M
– –
-37,838
Closed -$329K
KPTI icon
45
Karyopharm Therapeutics
KPTI
$59.7M
– –
-35,632
Closed -$464K
KROS icon
46
Keros Therapeutics
KROS
$628M
– –
-74,288
Closed -$3.39M
KURA icon
47
Kura Oncology
KURA
$707M
– –
-36,242
Closed -$746K
1
2